Workflow
Lepu Medical(300003)
icon
Search documents
乐普医疗收盘下跌2.27%,滚动市盈率236.64倍,总市值339.83亿元
Sou Hu Cai Jing· 2025-08-19 09:22
8月19日,乐普医疗今日收盘18.07元,下跌2.27%,滚动市盈率PE(当前股价与前四季度每股收益总和 的比值)达到236.64倍,总市值339.83亿元。 从行业市盈率排名来看,公司所处的医疗器械行业市盈率平均59.49倍,行业中值40.19倍,乐普医疗排 名第115位。 股东方面,截至2025年3月31日,乐普医疗股东户数94228户,较上次增加583户,户均持股市值35.28万 元,户均持股数量2.76万股。 乐普(北京)医疗器械股份有限公司的主营业务是医疗器械、药品、医疗服务及健康管理。公司的主要产 品是医疗器械、药品、医疗服务及健康管理。 最新一期业绩显示,2025年一季报,公司实现营业收入17.36亿元,同比-9.67%;净利润3.79亿元,同 比-21.44%,销售毛利率64.03%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)13乐普医疗236.64137.622.21339.83亿行业平均 59.4955.005.10121.17亿行业中值40.1939.642.9559.18亿1九安医疗11.6511.780.92196.54亿2英科医疗 15.3616.561.37242. ...
中证全指医疗保健设备与服务指数上涨1.49%,前十大权重包含新产业等
Sou Hu Cai Jing· 2025-08-15 15:25
Core Viewpoint - The China Securities Index for Healthcare Equipment and Services has shown significant growth, indicating a positive trend in the healthcare sector [1]. Group 1: Index Performance - The CSI Healthcare Equipment and Services Index increased by 1.49%, reaching 15,129.06 points, with a trading volume of 32.457 billion [1]. - Over the past month, the index has risen by 9.35%, by 9.86% over the last three months, and by 8.89% year-to-date [1]. Group 2: Index Composition - The index is composed of listed companies in the healthcare sector, reflecting the overall performance of these companies [1]. - The top ten weighted companies in the index include Mindray Medical (9.08%), United Imaging (7.41%), Aier Eye Hospital (7.13%), and others [1]. - The index's holdings are primarily from the Shenzhen Stock Exchange (59.69%) and the Shanghai Stock Exchange (40.31%) [1]. Group 3: Industry Representation - The index exclusively represents the pharmaceutical and healthcare industry, with a 100% allocation to this sector [1]. Group 4: Index Adjustment and Fund Tracking - The index samples are adjusted biannually, with changes implemented on the next trading day following the second Friday of June and December [2]. - Public funds tracking the healthcare index include various Southern and Tianhong funds, as well as ETFs from multiple asset management companies [2].
能上学、能看病,北京首个社区养老综合体长啥样?
Bei Jing Shang Bao· 2025-08-14 14:13
养老服务供给正出现全新模式,位于北京市海淀区半壁店二街的半壁店·长者照护之家(以下简称"长者 照护之家")即是一个典型代表。长者照护之家是乐普瑞康(北京)养老服务管理有限公司(以下简 称"乐普养老")在京打造的首个社区养老综合体,可为入住长者照护之家及周边社区的老年人提供综合 性、普惠性、专业化的养老服务。 长者照护之家于2024年11月开业运营,面向家庭、社区提供全方位可持续的照护支持。 长者照护之家共六层,划分为多个功能区,共有125间精装居室、300张床位。一层设有老年大学、托养 服务区、社区食堂、社区卫生服务站、田村路街道养老服务中心;二、三层设有失智照护专区;五、六 层设有失能照护专区。其中,一层的社区食堂已挂牌"海淀食堂"。 据医养康(北京)健康管理有限公司(以下简称"医养康")董事长、乐普养老总经理余立新介绍,长者 照护之家由乐普(北京)医疗器械股份有限公司(以下简称"乐普医疗")与医养康联合打造,依托智慧 养老照护平台,一站式提供生活照料、医疗保健、健康管理、心理慰藉等持续性养老照护,满足长者全 生命周期全生活场景的服务需求。在付费方面,长者照护之家实现了政府补贴一部分、长者自付一部分 的模式 ...
2025年中国生物医药材料中游产品市场现状——冠状动脉支架 药物洗脱支架占主导地位【组图】
Qian Zhan Wang· 2025-08-13 05:14
Core Insights - The coronary artery stent market in China is projected to reach approximately $7.0 billion by 2024, with a year-on-year growth of 6.4% [5][6]. Market Overview - In 2023, 8.368 million patients were hospitalized for coronary heart disease, with 1.901 million undergoing PCI (Percutaneous Coronary Intervention), where stent placement accounted for 81.2% of these procedures [3][6]. Product Structure - Drug-eluting stents (DES) dominate the market, expected to account for 69% of market revenue in 2024. The increasing prevalence of hypertension and diabetes due to aging populations and lifestyle changes is driving demand for DES [7][6]. Development Trends - **Material Innovation**: New alloy materials such as platinum-chromium and nickel-titanium are increasingly used due to their superior mechanical properties and biocompatibility. Biodegradable materials like polylactic acid and polycaprolactone are also being adopted to mitigate long-term foreign body reaction risks [11]. - **Functional Innovation**: Improvements in drug carriers for drug-eluting stents enhance drug release efficiency, reducing the risk of late thrombosis. Smart stents integrating sensors can monitor physiological parameters in real-time and adjust drug release accordingly [11].
中证全指医疗保健设备与服务指数上涨0.76%,前十大权重包含爱尔眼科等
Sou Hu Cai Jing· 2025-08-12 15:20
Core Viewpoint - The China Securities Index for Healthcare Equipment and Services has shown significant growth, with a 9.79% increase over the past month and a 13.13% increase over the past three months, indicating a strong performance in the healthcare sector [1]. Group 1: Index Performance - The China Securities Index for Healthcare Equipment and Services rose by 0.76% to 15,136.64 points, with a trading volume of 38.83 billion yuan [1]. - Year-to-date, the index has increased by 9.74% [1]. Group 2: Index Composition - The index is composed of listed companies in the healthcare sector, reflecting the overall performance of these companies [1]. - The top ten weighted companies in the index include: - Mindray Medical (9.04%) - United Imaging (7.59%) - Aier Eye Hospital (7.05%) - Aimeike (3.3%) - Huatai Medical (2.95%) - Lepu Medical (2.79%) - New Industry (2.64%) - Yuyue Medical (2.52%) - Meinian Onehealth (1.93%) - Yingke Medical (1.92%) [1]. Group 3: Market Distribution - The index's holdings are primarily listed on the Shenzhen Stock Exchange (59.62%) and the Shanghai Stock Exchange (40.38%) [1]. - The healthcare sector accounts for 100% of the index's holdings [1]. Group 4: Index Adjustment and Fund Tracking - The index samples are adjusted biannually, with adjustments occurring on the next trading day after the second Friday of June and December [2]. - Public funds tracking the healthcare index include various Southern and Tianhong funds, as well as ETFs from multiple financial institutions [2].
ETF日报|沪指7连阳续刷年内新高,512000高频溢价!“AI双子星”闪耀全场,寒武纪天量暴拉20CM,159363大涨3%创新高
Sou Hu Cai Jing· 2025-08-12 14:04
Market Overview - The market continues its upward trend with all three major indices reaching new highs for the year, with the Shanghai Composite Index achieving a seven-day winning streak and peaking at 3669.04 points [1] - A-shares saw a total trading volume of 1.91 trillion yuan, marking a significant increase in market activity over the past two days [1] Technology Sector - The technology growth sector is thriving, with significant gains in various ETFs, particularly those focused on AI and hard technology [1] - The AI sector is highlighted as a key focus, with stocks like Cambricon Technologies hitting the daily limit and achieving historical highs in trading volume and price [1] - The Huabao Entrepreneurial AI ETF (159363) surged by 3.03%, reaching a new listing high, reflecting strong investor interest [1][4] Financial Sector - The financial sector is also performing well, with brokerage stocks leading the charge, as evidenced by Guosheng Financial Holdings hitting the daily limit [2] - The top-performing brokerage ETF (512000) experienced high-frequency premiums, indicating strong market confidence [2] - Bank stocks are recovering, with Agricultural Bank of China achieving new highs for six consecutive days [2] AI and Cloud Computing - Positive news in the AI sector includes Huawei's announcement of a breakthrough in AI inference technology, which is expected to accelerate AI application growth [6][13] - The capital expenditure of major cloud companies is projected to exceed $330 billion by 2025, indicating robust growth in the AI and cloud computing sectors [6] - The entrepreneurial AI index has seen a cumulative increase of nearly 35% this year, outperforming other AI indices [6] Investment Opportunities - Analysts recommend focusing on the "AI main line" investment opportunities, particularly in the AI application and computing power sectors [8] - The domestic semiconductor industry is expected to benefit from increased demand for AI chips, driven by the need for domestic alternatives amid rising geopolitical tensions [13][14] - The medical sector is also gaining traction, with significant interest in brain-computer interface technologies and related stocks [15][17] ETF Performance - The Huabao Entrepreneurial AI ETF (159363) has become the largest in its category, with a trading volume of 2.67 billion yuan, reflecting high market activity [4][18] - The Huabao Sci-Tech AI ETF (589520) also performed well, with a peak increase of 3.12% during trading [9][14] Key Developments - The upcoming release of DeepSeek-R2 is generating excitement in the market, with expectations of significant advancements in AI capabilities [11] - The Ministry of Industry and Information Technology has outlined plans to promote the development of brain-computer interface technologies, indicating a growing focus on this innovative sector [17]
医疗器械概念股走强,相关ETF涨约2%
Sou Hu Cai Jing· 2025-08-12 02:34
Group 1 - The core viewpoint is that the medical device sector is experiencing a strong performance, with notable increases in stock prices for companies like Lepu Medical, Mindray, and United Imaging, indicating a positive market trend [1][2] - Medical-related ETFs have also seen a rise of approximately 2%, reflecting the overall strength of the sector [1][2] - Analysts suggest that increasing internationalization will provide more investment opportunities in the medical device sector, with several companies expected to achieve high growth in international business by 2025 [2] Group 2 - The performance of Hong Kong's medical device stocks has been strong this year, which is anticipated to influence the A-share market positively [2] - The investment opportunities in both A-share and Hong Kong medical device sectors are expected to continue to be prominent [2]
A股脑机接口概念股走强,麒盛科技、创新医疗涨停
Ge Long Hui A P P· 2025-08-12 02:20
Group 1 - The A-share market has seen a strong performance in brain-computer interface concept stocks, with notable increases in share prices for several companies [1] - Major gainers include Mailland, which rose nearly 18%, and Xiangyu Medical, which increased over 10% [1] - Other companies such as Qisheng Technology and Innovation Medical reached their daily limit up of 10%, while Chengyitong and Sanbo Brain Science rose over 8% [1] Group 2 - Detailed stock performance includes: - Mailland (688273) with a 17.99% increase and a market cap of 5.28 billion, year-to-date increase of 129.09% [2] - Xiangyu Medical (688626) with a 10.33% increase and a market cap of 10.2 billion, year-to-date increase of 119.06% [2] - Qisheng Technology (603610) with a 10.01% increase and a market cap of 5.083 billion, year-to-date increase of 15.14% [2] - Innovation Medical (002173) with a 9.99% increase and a market cap of 9.086 billion, year-to-date increase of 158.67% [2] - Chengyitong (300430) with an 8.37% increase and a market cap of 6.329 billion, year-to-date increase of 51.81% [2] - Sanbo Brain Science (301293) with an 8.19% increase and a market cap of 12.8 billion, year-to-date increase of 43.94% [2] - Aipeng Medical (300753) with a 6.54% increase and a market cap of 4.601 billion, year-to-date increase of 107.58% [2] - Weisi Medical (688580) with a 5.91% increase and a market cap of 5.376 billion, year-to-date increase of 104.65% [2] - Lepu Medical (300003) with a 5.61% increase and a market cap of 34.4 billion, year-to-date increase of 62.75% [2]
创新高!这一概念股连续涨停
第一财经· 2025-08-08 14:33
Core Viewpoint - The brain-computer interface (BCI) industry is expected to experience significant growth, with 2023 being a pivotal year for its development and application across various sectors [2][8]. Group 1: Market Performance - The BCI concept stocks have seen a strong rally, with several companies like Sainuo Medical, Guangdian Co., and Shangrong Medical hitting their daily price limits [4]. - Notable stock performances include Lide Man and Botuo Bio, which rose over 11%, and Meilan De, which increased by 10% [4]. Group 2: Technological Advancements - BCI technology connects the brain with external devices for information exchange, showing promise in medical fields such as disease diagnosis and treatment [6]. - Significant advancements have been made in BCI technology, particularly in biomedical applications, neuro-rehabilitation, and intelligent robotics [6]. Group 3: Industry Outlook - According to McKinsey, the global market for BCI medical applications is projected to reach $40 billion by 2030 and $145 billion by 2040 [7]. - The Chinese BCI industry, although starting late, is rapidly developing, with multiple policies introduced since 2025 to support its growth [9][10]. Group 4: Policy Support - Recent government initiatives aim to accelerate the commercialization of BCI technology, with specific action plans released by cities like Beijing and Shanghai [9][10]. - The Ministry of Industry and Information Technology and other departments have set ambitious goals for the BCI industry over the next five years, focusing on technological breakthroughs and establishing a robust industrial ecosystem [10]. Group 5: Application Areas - The BCI industry has two primary application areas: serious medical applications, such as rehabilitation for stroke and spinal injury patients, and consumer applications addressing issues like sleep disorders [11]. - A significant challenge for the industry is to reduce costs, making BCI technologies more accessible to the general public [11][12].
脑机接口板块大涨 机构圈出这些机会
Di Yi Cai Jing· 2025-08-08 06:05
脑机接口板块今日大涨,赛诺医疗、广电股份涨停,乐普医疗涨超8%。 中泰证券指出,脑机接口获政策强支持力度,产业迈入加速成长阶段。非植入式产品在政策支持下,商 业化落地速度有望加快,植入式设备有望凭借更高的信号分辨率与操作精度,为高精度医疗场景提供技 术支持。建议关注非植入式领域软硬件或产品研发进展较快的标的。 湘财证券指出,作为医疗领域前沿技术,脑机接口的应用将在态者检测、疾病康复、技能替代等方向逐 步落地。建议关注积极布局脑机接口技术的相关公司。 消息面上,工信部等七部门印发《关于推动脑机接口产业创新发展的实施意见》。 ...